Fatty acid binding protein 4 as a biomarker for improvement of type 2 diabetes

被引：0
|
作者：
Mehra, R. [1 ]
Stentz, F. [1 ]
机构：
[1] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
来源：
AMERICAN JOURNAL OF THE MEDICAL SCIENCES | 2023年 / 365卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
140
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [31] Serum fatty acid-binding protein 4 levels and responses of pancreatic islet β-cells and α-cells in patients with type 2 diabetes
    Wang, Hong
    Cao, Jie
    Su, Jian-bin
    Wang, Xue-qin
    Wang, Xing
    Zhang, Dong-mei
    Wang, Xiao-hua
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [32] Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes
    Cabre, A.
    Lazaro, I.
    Girona, J.
    Manzanares, J.
    Marimon, F.
    Plana, N.
    Heras, M.
    Masana, L.
    JOURNAL OF INTERNAL MEDICINE, 2007, 262 (04) : 496 - 503
  • [33] Interaction of type 2 diabetes with the codon 54 polymorphism of the fatty acid binding protein 2 gene leads to hypertriglyceridemia
    Georgopoulos, A
    Aras, O
    Tsai, MY
    DIABETES, 2000, 49 : A83 - +
  • [34] Plasma fatty acid binding protein (FABP4) is an early biomarker of metabolic dysfunction
    Witczak, J. K.
    Min, T.
    Prior, S. L.
    Stephens, J. W.
    James, P. E.
    Rees, A.
    DIABETIC MEDICINE, 2017, 34 : 52 - 53
  • [35] Fatty Acid Binding Protein 4 Could Be a Linking Biomarker Between Periodontitis and Systemic Diseases
    Song, Jiwon
    Ok, Soo-Min
    Kwon, Eun-Young
    Kim, Hyun-Joo
    Lee, Ju-Youn
    Joo, Ji-Young
    BIOMEDICINES, 2025, 13 (02)
  • [36] Unlike type 2 Diabetes, type 1 does not interact with the codon 54 polymorphism of the fatty acid binding protein 2 gene
    Georgopoulos, A
    Aras, O
    Noutsou, M
    Tsai, MY
    DIABETES, 2001, 50 : A8 - A8
  • [37] Unlike type 2 diabetes, type 1 does not interact with the codon 54 polymorphism of the fatty acid binding protein 2 gene
    Georgopoulos, A
    Aras, O
    Noutsou, M
    Tsai, MY
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08): : 3735 - 3739
  • [38] Increased intestinal-fatty acid binding protein in obesity-associated type 2 diabetes mellitus
    Tahapary, Dicky L.
    Fatya, Atikah I.
    Kurniawan, Farid
    Marcella, Cicilia
    Rinaldi, Ikhwan
    Tarigan, Tri J. E.
    Harbuwono, Dante S.
    Yunir, Em
    Soewondo, Pradana
    Purnamasari, Dyah
    PLOS ONE, 2023, 18 (01):
  • [39] CIRCULATING ADIPOCYTE FATTY ACID BINDING PROTEIN LEVELS PREDICT THE PROGRESSION OF NEPHROPATHY IN TYPE 2 DIABETES MELLITUS
    Lee, C. H.
    Hui, E.
    Woo, Y. C.
    Yeung, C. Y.
    Chow, W. S.
    Yuen, M.
    Fong, C.
    Xu, A. M.
    Lam, K.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S10 - S10
  • [40] Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target
    Lehmann, F
    Haile, S
    Axen, E
    Medina, C
    Uppenberg, J
    Svensson, S
    Lundbäck, T
    Rondahl, L
    Barf, T
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (17) : 4445 - 4448
12345